Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis

Oncology Letters

Volumn 7, Issue 1, 2014, Pages 28-34

  Dong, Zhizhen ^a   Yao, Min ^a   Zhang, Haijian ^a   Wang, Li ^a   Huang, Hua ^a   Yan, Meijuan ^a   Wu, Wei ^a   Yao, Dengfu ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Annexin A2; Hepatitis B virus; Hepatocellular carcinoma; Metastasis; Small hairpin RNA; Upregulation

Indexed keywords

LIPOCORTIN 2; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANNEXIN A2 GENE; ARTICLE; CARCINOGENICITY; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE ACTIVATION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; METASTASIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TUMOR INVASION; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 84888405822     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1663     Document Type: Article

References (28)

1. El-Serag HB: Hepatocellular carcinoma. N Engl J Med 365: 1118-1127, 2011.
2. Frenette C and Gish RG: Hepatocellular carcinoma: molecular and genomic guideline for the clinician. Clin Liver Dis 15: 307-321, vii-x, 2011.
3. Yeh FS, Yu MC, Mo CC, et al: Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 49: 2506-2509, 1989.
4. Yao D, Jiang D, Huang Z, et al: Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. Cancer 88: 761-769, 2000.
5. Yao M, Yao DF, Bian YZ, et al: Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 10: 289-294, 2011.
6. Li S, Yao DF, Wang L, et al: Expression characteristics of hypoxia-inducible factor-1α and its clinical values in diagnosis and prognosis of hepatocellular carcinoma. Hepat Mon 11: 821-828, 2011.
7. Alison MR, Nicholson LJ and Lin WR: Chronic inflammation and hepatocellular carcinoma. Recent Results Cancer Res 185: 135-148, 2011.
8. Thomas MB and Zhu AX: Hepatocellular carcinoma: the need for progress. J Clin Oncol 23: 2892-2899, 2005.
9. Gonzalez SA and Keeffe EB: Diagnosis of hepatocellular carcinoma: role of markers and liver biopsy. Clin Liver Dis 15: 297-306, 2011.
10. DuBray BJ Jr, Chapman WC and Anderson CD: Hepatocellular carcinoma: a review of the surgical approaches to management. Mo Med 108: 195-198, 2011.
11. Portolani N, Baiocchi GL, Coniglio A, et al: Limited liver resection: a good indication for the treatment of hepatocellular carcinoma in elderly patients. Jpn J Clin Oncol 41: 1358-1365, 2011.
12. Shimizu I, Yao DF, Horie C, et al: Mutations in a hydrophilic part of the core gene of hepatitis C virus in patients with hepatocellular carcinoma in China. J Gastroenterol 32: 47-55, 1997.
13. Block TM, Mehta AS, Fimmel CJ and Jordan R: Molecular viral oncology of hepatocellular carcinoma. Oncogene 22: 5093-5107, 2003.
14. van Malenstein H, van Pelt J and Verslype C: Molecular classification of hepatocellular carcinoma anno 2011. Eur J Cancer 47: 1789-1797, 2011.
15. Sharma M, Ownbey RT and Sharma MC: Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Pathol 88: 278-286, 2010.
16. Zheng L, Foley K, Huang L, et al: Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One 6: e19390, 2011.
17. Mohammad HS, Kurokohchi K, Yoneyama H, et al: Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int J Oncol 33: 1157-1163, 2008.
18. Zhao P, Zhang W, Tang J, et al: Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci 101: 387-395, 2010.
19. Bao H, Jiang M, Zhu M, et al: Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. Int J Hematol 90: 177-185, 2009.
20. Hayes MJ, Longbottom RE, Evans MA and Moss SE: Annexinopathies. Subcell Biochem 45: 1-28, 2007.
21. Gerke V and Moss SE: Annexins: from structure to function. Physiol Rev 82: 331-371, 2002.
22. Zhang HJ, Yao DF, Yao M, et al: Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma. World J Gastroenterol 18: 5897-5904, 2012.
23. Ohno Y, Izumi M, Kawamura T, et al: Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br J Cancer 101: 287-294, 2009.
24. Ruan J, Liu F, Chen X, et al: Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line. Int J Mol Med 28: 497-503, 2011.
25. Yoon SY, Kim JM, Oh JH, et al: Gene expression profiling of human HBV-and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. Int J Oncol 29: 315-327, 2006.
26. Tazi el M, Essadi I, M'Rabti H, et al: Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma. N Am J Med Sci 3: 167-175, 2011.
27. Grewal T and Enrich C. Annexins-modulators of EGF receptor signalling and trafficking. Cell Signal 21: 847-858, 2009.
28. Yao M, Yao DF, Bian YZ, et al: Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 12: 171-179, 2013.